8.1.5 Other antineoplastic drugs

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

1340 library items in 8.1.5 Other antineoplastic drugs

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

8: Malignant disease and immunosuppression (remove) , 8.1 Cytotoxic drugs (remove) , 8.1.5 Other antineoplastic drugs (remove)

Sort by: Display summary:

Results 1 - 10 of 1340

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

SMC does not recommend ipilimumab (Yervoy®) for advanced melanoma

Source: Scottish Medicines Consortium (SMC),
Date published: 15/05/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: skin | Drug reviews | Scottish Medicines Consortium

NeLM Area:

Evidence > Drug Specific Reviews

Link to drug advice
2.

SMC accepts everolimus (Afinitor®) for use in the treatment of neuroendocrine tumours of pancreatic origin (pNET)

Source: Scottish Medicines Consortium (SMC),
Date published: 15/05/2012

Category:

8.1.5 Other antineoplastic drugs | Drug reviews | Oncology | Scottish Medicines Consortium

NeLM Area:

Evidence > Drug Specific Reviews

Link to drug advice
3.

SMC does not recommend bevacizumab (Avastin®) for first-line treatment of metastatic breast cancer

Source: Scottish Medicines Consortium (SMC),
Date published: 15/05/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: breast | Drug reviews | Scottish Medicines Consortium

NeLM Area:

Evidence > Drug Specific Reviews

Link to drug advice
4.

London Cancer New Drugs Group Rapid Review: Bortezomib as first line induction prior to melphalan and ASCT in untreated symptomatic multiple myeloma patients

Source: London Cancer New Drugs Group,
Date published: 15/05/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: other | Drug reviews

NeLM Area:

Evidence > Drug Specific Reviews

LCNDG_Bortezomib_1st_line
5.

Interim analysis of phase III study of cetuximab for stage III colon cancer

Source: PharmaLive,
Date published: 14/05/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: gastroenterological

NeLM Area:

News

Link
6.

Final NICE guidance does not recommend the use of cabazitaxel for the 2nd line treatment of hormone refractory, metastatic prostate cancer

Source: NICE,
Date published: 11/05/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: prostate | National Institute of Clinical Excellence (NICE)

NeLM Area:

News

NICE guidance

Press release
7.

NICE draft guidance supports use of erlotinib for first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer

Source: NICE,
Date published: 10/05/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: lung | Clinical guidelines | National Institute of Clinical Excellence (NICE)

NeLM Area:

News

Press release

Link to draft guidance
8.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: NOA-08 randomised, phase III trial

Source: Lancet Oncology,
Date published: 10/05/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: other | Care of Older People

NeLM Area:

News

Abstract

Comment- full text access for subscribers only
9.

NHS HTA: Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia

Source: No information given,
Date published: 09/05/2012

Category:

8.1.5 Other antineoplastic drugs | Leukaemia | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Drug Specific Reviews

Link
10.

NHS HTA: Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia

Source: NHS HTA,
Date published: 09/05/2012

Category:

8.1.5 Other antineoplastic drugs | Leukaemia | National Institute of Clinical Excellence (NICE)

NeLM Area:

Evidence > Drug Specific Reviews

Link

Results 1 - 10 of 1340

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next